Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cryoport, Inc. has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Château, France.
read more
Friday, February 05, 2021
Reflect Scientific has announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration.
read more
Tuesday, November 18, 2025
CRScube has announced the successful acquisition of Mednet. The transaction unites two respected eClinical technology vendors with complementary strengths and a shared commitment to thoughtful innovation, collaboration, and care for the people behind...
read more
Wednesday, March 27, 2019
Crown Bioscience announced that parent company, JSR Corporation, has entered into a strategic partnership with Hubrecht Organoid Technology (HUB).
read more
Crown Bioscience has enhanced its existing portfolio of humanized drug target models by launching a new transgenic CD3E model to advance development of immuno-oncology drugs.
read more
Crown Bioscience announced the launch of pre-clinical models of IBD and RA to help inform decision making in pre-clinical drug development.
read more
Wednesday, March 14, 2018
Crown Bioscience has been selected by Phanes Therapeutics as a strategic partner to advance their oncology drug discovery pipeline.
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces that it has been selected by Pierre Fabre ...
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Crown Bioscience announced the appointment of Jean-Pierre Wery, PhD as executive chairman of the board effective immediately.
read more
Wednesday, November 29, 2017
Crown Bioscience and DSI announced the successful development of an enhanced method for preclinical obesity and type 2 diabetes studies in partnership.
read more
Crown Bioscience announced a licensing agreement with Charles River International Research Models and Services business.
read more
Thursday, February 11, 2016
Crown Bioscience Inc. has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.
read more
Crown Bioscience has announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, USA, and Asia to support client’s needs with a comprehensive collection of validated models and services for in vivo ...
read more
Tuesday, January 20, 2026
Crown Bioscience announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accreditation. This milestone builds on the site’s Clinical Laboratory Improvement Amendments (CLIA) certification, obtained in July 2025, ...
read more